116 related articles for article (PubMed ID: 9887666)
1. [Drug clinics. Drug of the month. Formoterol (Oxis turbohaler)].
Scheen AJ
Rev Med Liege; 1998 Nov; 53(11):715-8. PubMed ID: 9887666
[TBL] [Abstract][Full Text] [Related]
2. The use of inhaled formoterol in the treatment of asthma.
Berger WE
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
[TBL] [Abstract][Full Text] [Related]
3. Formoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease.
Prenner BM
Expert Opin Pharmacother; 2007 Dec; 8(17):3069-84. PubMed ID: 18001266
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
[TBL] [Abstract][Full Text] [Related]
5. Budesonide plus formoterol for reliever therapy in asthma.
Pedersen S
Lancet; 2006 Aug; 368(9537):707-8. PubMed ID: 16935666
[No Abstract] [Full Text] [Related]
6. [Changes in specific airway resistance after powder inhalation of formoterol or salmeterol in moderate bronchial asthma].
Sill V; Bartuschka B; Villiger B; Ortland C; Domej W
Pneumologie; 1999 Jan; 53(1):4-9. PubMed ID: 10091511
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma.
Jenkins C; Kolarikova R; Kuna P; Caillaud D; Sanchis J; Popp W; Pettersson E
Respirology; 2006 May; 11(3):276-86. PubMed ID: 16635085
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma.
Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D
Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143
[TBL] [Abstract][Full Text] [Related]
9. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study].
Lebecque P; Vliers S; De Saint-Moulin T; Godding V
Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426
[TBL] [Abstract][Full Text] [Related]
10. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics.
Tan S; Hall IP; Dewar J; Dow E; Lipworth B
Lancet; 1997 Oct; 350(9083):995-9. PubMed ID: 9329515
[TBL] [Abstract][Full Text] [Related]
11. Inhalation devices for long-acting beta2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD.
Molimard M; Till D; Stenglein S; Singh D; Krummen M
Curr Med Res Opin; 2007 Oct; 23(10):2405-13. PubMed ID: 20350055
[TBL] [Abstract][Full Text] [Related]
12. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
13. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
[TBL] [Abstract][Full Text] [Related]
14. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
15. Bronchodilation and bronchoprotection in asthmatic preschool children from formoterol administered by mechanically actuated dry-powder inhaler and spacer.
Nielsen KG; Bisgaard H
Am J Respir Crit Care Med; 2001 Jul; 164(2):256-9. PubMed ID: 11463597
[TBL] [Abstract][Full Text] [Related]
16. [The beta-2-agonists in asthma in infants and young children].
Dubus JC; Mély L; Stremler-Lebel N; Chabrol B
Arch Pediatr; 2002 Aug; 9 Suppl 3():384s-389s. PubMed ID: 12205813
[TBL] [Abstract][Full Text] [Related]
17. Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma.
Pohunek P; Kuna P; Jorup C; De Boeck K
Pediatr Allergy Immunol; 2006 Sep; 17(6):458-65. PubMed ID: 16925692
[TBL] [Abstract][Full Text] [Related]
18. Regular inhaled beta-adrenergic agonists in the treatment of bronchial asthma: beneficial or detrimental?
Nelson HS; Szefler SJ; Martin RJ
Am Rev Respir Dis; 1991 Aug; 144(2):249-50. PubMed ID: 1677552
[No Abstract] [Full Text] [Related]
19. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
20. Bronchodilator resuscitation in the emergency department. Part 2 of 2: dosing strategies.
Fink J; Dhand R
Respir Care; 2000 May; 45(5):497-512. PubMed ID: 10813227
[No Abstract] [Full Text] [Related]
[Next] [New Search]
